Do Men Get Kidney Stones More Than Women

You're at a backyard barbecue. "Yeah, my dad had them. Someone mentions kidney stones. Even so, another person winces and says, "My cousin passed one last month — said it was worse than childbirth. " Someone else nods. My grandpa too. Runs in the family, but only the men Small thing, real impact..

Quick note before moving on Small thing, real impact..

You pause. Consider this: is that actually true? Do men really get kidney stones more than women? Or is it just one of those things everyone thinks they know?

Short answer: yes. For a long time, men were diagnosed two to three times more often. But that gap is shrinking. Fast. And the reasons behind it? They're not what most people assume.

What Is the Gender Gap in Kidney Stones

Kidney stones — hard deposits of minerals and salts that form inside your kidneys — have been tracked by gender for decades. Historically, the numbers were stark. In the 1970s and 80s, men were diagnosed at rates roughly three times higher than women. Lifetime risk for men hovered around 10–12%. For women, it was closer to 5–6% That's the part that actually makes a difference..

Some disagree here. Fair enough That's the part that actually makes a difference..

That's not a small difference. It shaped how doctors thought about risk, how researchers designed studies, even how patients were counseled.

But here's what changed: starting in the 1990s, women's rates began climbing. Practically speaking, steadily. Even so, by the 2010s, the male-to-female ratio had dropped from 3:1 to closer to 1. Which means 5:1 in many Western countries. In some age groups — particularly women aged 18–39 — incidence has nearly doubled in two decades It's one of those things that adds up..

This is the bit that actually matters in practice.

So men still get them more. But "more" is doing a lot of heavy lifting these days Not complicated — just consistent. That alone is useful..

The numbers keep shifting

A 2022 study using U.S. insurance claims data found that between 1997 and 2012, the annual incidence of kidney stones rose 16% in men but 45% in women. The sharpest spike? That's why women aged 18–39. Their rate jumped from 79 to 152 cases per 100,000 people.

That's not noise. That's a trend.

And it's not just the U.S. Similar patterns show up in South Korea, the UK, and parts of Europe. The gap is narrowing globally Worth keeping that in mind. Still holds up..

Why It Matters / Why People Care

If you're a guy, you might think, "Great, I'm in the high-risk group. Plus, nothing new. " If you're a woman, you might assume you're safe. Both assumptions are dangerous.

For men: complacency kills prevention

Because kidney stones have long been framed as a "man's problem," many men treat them as inevitable — something you just deal with when it happens. And men still have higher recurrence rates. But the same factors driving the rise in women (diet, weight, hydration) are hitting men too. Once you've had one stone, your chance of another within 5–7 years is 35–50%. That's not a one-time event. That's a chronic condition waiting to happen Which is the point..

For women: the blind spot is real

Many women — and honestly, some doctors — still underestimate the risk. " "Just bad cramps.That means symptoms get dismissed. Now, a 2018 survey found that only 27% of women knew kidney stones were becoming more common in their gender. "It's probably a UTI.Still, " "Maybe ovarian cyst. " Delayed diagnosis means more ER visits, more imaging, more procedures No workaround needed..

For everyone: the cost is staggering

Kidney stones cost the U.Repeat CT scans. S. Ureteroscopies. Stents. Lost workdays. healthcare system over $10 billion annually. In real terms, lithotripsy. The financial hit is real — and rising with the incidence Which is the point..

How It Works: Why Men Still Lead (But Women Are Catching Up)

There's no single reason. Day to day, it's a collision of biology, behavior, and environment. Let's break it down.

Anatomy isn't destiny — but it plays a role

The male urethra is longer. That sounds like it would make passing stones harder, not easier. But the real anatomical difference? The prostate. Benign prostatic hyperplasia (BPH) — extremely common in older men — can cause urinary stasis. Stagnant urine = more time for crystals to grow. Also, men have higher baseline urinary calcium excretion. Not by a little. Which means by 20–30% on average. That's a direct thermodynamic push toward stone formation The details matter here..

Hormones: the estrogen shield, the testosterone push

At its core, where it gets interesting Most people skip this — try not to..

Estrogen appears protective. It increases urinary citrate (a natural stone inhibitor), decreases calcium excretion, and may reduce oxalate absorption. Postmenopausal women lose that protection — and their stone risk rises to nearly match men's age-matched peers.

Testosterone, on the other hand, may promote stone formation. Animal studies show it increases urinary oxalate and decreases citrate. Human data is messier, but men with lower testosterone (hypogonadism) actually have lower stone rates. Supplementation? Some urologists worry it could raise risk. The jury's still out — but the hormonal signal is real Which is the point..

Diet: the great equalizer

Here's where the gap narrows.

Men traditionally ate more animal protein, more sodium, less fruit and vegetables. Low produce → less potassium, less magnesium, less citrate. Practically speaking, high sodium → more calcium excretion. That's why high animal protein → more uric acid, less citrate, more calcium in urine. All stone-promoting.

But women's diets have shifted. More processed food. More high-protein diets (keto, paleo, intermittent fasting). More sodium. Less water. The "standard American diet" stopped being gendered a while ago.

And then there's fructose. Men still drink more of it. Soda, energy drinks, sweetened teas. High-fructose corn syrup intake correlates strongly with stone risk — independent of weight. But women are closing that gap too Worth knowing..

Obesity and metabolic syndrome

Obesity is a stone risk factor. Period. It changes urine chemistry: lower pH, higher uric acid, higher oxalate, lower citrate. So naturally, it also increases insulin resistance — which reduces ammonium production in the kidney, lowering urinary pH further. That's why acidic urine = uric acid stones. And calcium oxalate stones love acidic environments too.

In the 1990s, obesity rates were similar between genders. Today? Women have slightly higher rates of severe obesity (BMI ≥40). Also, that matters. Visceral fat is metabolically active.

Visceral fat and urinary chemistry

Visceral adipocytes are not inert storage units; they secrete a cocktail of cytokines, adipokines, and free fatty acids that directly alter renal handling of stone‑forming solutes Worth keeping that in mind. Turns out it matters..

• Inflammation: Elevated interleukin‑6 and tumor‑necrosis factor‑α impair tubular reabsorption of citrate, driving urinary citrate down by roughly 10‑15 % in men and women with BMI ≥ 35. Low citrate removes a key inhibitor of calcium‑oxalate nucleation.

• Oxidative stress: Reactive oxygen species generated by hypertrophic fat cells increase tubular production of oxalate via the enzyme NADPH oxidase‑mediated pathway, raising urinary oxalate concentrations by 5‑8 % even after adjusting for dietary intake.

• Adipokine disruption: Leptin resistance, common in severe obesity, blunts the renal ammonium‑generating pathway, lowering urinary pH and favoring uric‑acid precipitation. Conversely, adiponectin, which normally enhances citrate excretion, falls sharply with visceral fat accumulation Worth keeping that in mind. Nothing fancy..

• Calcium handling: Visceral fat upregulates parathyroid hormone‑related peptide (PTHrP) circulating levels, prompting the kidneys to excrete more calcium. The net effect is an additional 20‑30 mg of calcium per day in the urine—enough to tip the supersaturation balance toward calcium‑oxalate crystals That's the part that actually makes a difference..

Collectively, these metabolic disturbances create a urinary environment that mirrors the classic “stone‑prone” profile: low pH, low citrate, high calcium, oxalate, and uric acid. The gender gap narrows here because severe obesity now affects women at rates equal to or higher than men, especially in the ≥ BMI 40 category.

Lifestyle modifiers that amplify or blunt risk

You'll probably want to bookmark this section.

Prevention: moving beyond “one‑size‑fits‑all”

1. Hydration targets – Aim for ≥ 2.5 L (men) and ≥ 2.0 L (women) of total water intake daily, with at least 1.5 L from plain water. Personalized urine‑output goals (≈ 2 L day⁻¹) can be tracked with simple apps No workaround needed..

2. Dietary tailoring – For men, moderating animal protein and sodium remains a high‑yield strategy. For women, the focus should shift toward limiting processed foods, reducing fructose‑sweetened beverages, and ensuring adequate fruit/vegetable intake to boost citrate and potassium.

3. Weight management – Even a modest 5‑7 % reduction in body weight can raise urinary citrate by ~10 % and lower oxalate excretion by ~5 %. Structured programs combining caloric control, resistance training, and behavioral counseling are most effective.

4. Hormone awareness – While the evidence is still evolving, clinicians should consider testosterone supplementation cautiously in hypogonadal men, and evaluate estrogen status in postmenopausal women, especially those with low bone density or metabolic syndrome.

5. Targeted supplementation – Potassium citrate remains the cornerstone prophylactic agent for both sexes, but dosing may need to be higher in individuals with severe obesity due to greater baseline acid load. Quercetin, magnesium, and phytate‑rich foods (e.g., legumes, whole grains) provide modest additional protection And that's really what it comes down to..

Looking ahead

The historic male predominance in nephrolithiasis is eroding as lifestyle patterns converge and obesity rates rise across genders. Future research should prioritize:

• Sex‑specific metabolic phenotyping to identify which obese women are most prone to calcium‑oxalate versus uric‑acid stones.
• Longitudinal hormone‑stone studies that tease apart the protective role of estrogen and the potential stone‑promoting effects of testosterone supplementation.
• Precision nutrition trials that test individualized dietary algorithms based on urinary chemistries, genotype, and microbiome profiles.

Conclusion

Anatomical differences give men a modest baseline advantage, but hormonal influences are nuanced, and diet and obesity now drive stone risk far more than gender alone. As women adopt dietary patterns historically associated with men—higher

As women adopt dietary patterns historically associated with men—higher intake of animal protein, sodium‑rich processed foods, and sugar‑sweetened beverages—their urinary profiles begin to mirror those traditionally seen in male stone formers: elevated calcium excretion, reduced citrate, and increased uric acid load. This convergence narrows the historic gender gap and underscores the importance of sex‑aware preventive strategies that go beyond simple hydration advice.

You'll probably want to bookmark this section.

Implications for Clinical Practice

• Screening: Routine metabolic evaluations (24‑hour urine for calcium, oxalate, citrate, uric acid, and pH) should be offered to women with obesity, metabolic syndrome, or a family history of stones, irrespective of age.
• Counseling: Dietitians can tailor advice by emphasizing plant‑based protein sources, limiting processed meats, and encouraging potassium‑rich fruits and vegetables that naturally boost citrate.
• Pharmacologic Adjuncts: In postmenopausal women with low estrogen states, selective estrogen receptor modulators (SERMs) that preserve bone density without markedly increasing urinary calcium may be considered, though data remain preliminary.

Public Health Perspectives
Policy initiatives that reduce sodium in packaged foods and curb marketing of high‑fructose beverages benefit both sexes but may have a disproportionate impact on women, who often bear the primary responsibility for household food preparation. Community‑based programs that combine cooking workshops with physical activity have shown promise in lowering stone incidence among overweight women in pilot trials.

Research Priorities

1. Microbiome‑Stone Axis: Emerging evidence links gut bacterial oxalate‑degrading capacity (e.g., Oxalobacter formigenes) to stone risk; sex‑specific microbiome profiling could reveal why certain obese women develop calcium‑oxalate stones despite similar dietary exposures.
2. Hormone‑Modulating Trials: Randomized studies testing low‑dose testosterone therapy in hypogonadal men versus placebo, with rigorous urinary chemistry endpoints, will clarify whether the hormone itself or associated changes in muscle mass drive risk.
3. Digital Phenotyping: Wearable sensors that track fluid intake, urine specific gravity, and physical activity in real time can feed into machine‑learning models that predict stone formation risk, allowing for personalized, dynamic interventions.

Conclusion

While anatomical differences once conferred men a modest advantage in nephrolithiasis, the evolving landscape of diet, obesity, and hormonal milieu has leveled the playing field. So effective prevention now hinges on recognizing that stone risk is driven less by gender per se and more by the interplay of dietary habits, metabolic health, and endocrine status. By embracing sex‑specific metabolic phenotyping, refining nutritional guidance, and leveraging emerging technologies, clinicians and public‑health officials can move beyond a one‑size‑fits‑all approach and deliver truly personalized stone‑prevention strategies for both men and women But it adds up..